V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Row
M
MRKAI Stock Diagnostic Report

Merck upgraded at Morgan Stanley after cancer trial win; RBC downgrades

Following the clinical success of the cancer vaccine co-developed with Moderna, Merck (MRK) was upgraded by Morgan Stanley, but downgraded by RBC Capital Markets due to valuation concerns.

View Source Article ↗
AI CATALYST SCORE50 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

MRK Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-08-25 10:34:43MRK85S-ClassView Report →
2026-08-20 14:27:55MRK50RowView Report →
2026-08-15 16:17:49MRK35RowView Report →
View Full History for MRK (Blueprint) →